The study, published in Telemedicine and e-Health, reviewed stroke care data from the stroke alert database of Mayo Clinic Hospital in Phoenix and compared 98 subjects who received care telepresence with 98 subjects who received usual stroke alert care.
They found the average time from stroke alert activation to delivering intravenous thrombolytic treatment was 8.6 minutes longer for patients in the telemedicine group than in the standard group. Additionally, for acute ischemic stroke patients, the average time duration was 18 minutes longer for those in the telemedicine group than in the standard group.
Researchers did note the safety outcomes between the two study groups were not significantly different.
They concluded that safety outcomes of telestroke services were “excellent,” but telestroke assessments also took longer. Researchers suggested telestroke may be preferred in situations when a vascular neurologist is not available for on-site care.
More articles on telemedicine:
Washington state introduces bill to reimburse patients for telemedicine services
Telemedicine helps revive rural Arizona hospital
DuPage Medical Group implements telemedicine platform
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
